Highlights:
-- The Ministry of Justice and Law of the Republic of Colombia granted ICC Labs a license for the cultivation of psychoactive (high-THC) cannabis plants.
-- The Ministry of Health of the Republic of Colombia granted ICC Labs a license to manufacture cannabis derivatives for medicinal purposes.
-- ICC Labs has become the first public Canadian company fully licensed for the production and distribution of cannabis in both Latin American countries that allow it.
ICC Labs Inc. ("ICC Labs" or the "Company") (TSX-V:ICC) is pleased to announce that the Ministry of Justice and Law of the Republic of Colombia has granted ICC Labs' Colombian subsidiary a license to cultivate psychoactive cannabis plants for medicinal purposes for domestic and international distribution. The Ministry of Health of the Republic of Colombia has also granted ICC Labs' Colombian subsidiary a license to manufacture cannabis derivatives for medicinal purposes. ICC Labs' Colombian licenses are each valid for a period of five years and are renewable upon request within three months of expiration.